Company intelligence / Profile preview

EB Pharma

Ownership: Private
Development stage: Other

Overview

EB Pharma is an established, fully integrated pharmaceutical company in Taiwan, focused on the sales and marketing of both innovator (branded, originator) and generic drug products at various life cycle stages. It has longstanding partnerships with multinational pharma companies and is the largest distributor of Novartis products in Taiwan.

Modalities: Small moleculeGeneric drugBranded drug
Industry: Biotech

Partnerships

Novartis (largest distributor in Taiwan; includes legacy Sandoz and Ciba-Geigy brands)Partnerships or representation with other multinational pharmaceutical innovators

Beyond the preview

Go deeper on EB Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EB Pharma.